This article first appeared on GuruFocus .
-
Underlying Net Income:$1.146 billion, up 9% year-over-year (from $1.05 billion).
-
Underlying EPS:$2.05, up 10% year-over-year.
-
Reported Net Income:$785 million, down from $1.1 billion a year ago, reflecting market-related impacts, acquisition/integration costs, and GreenOak restructuring costs.
-
Underlying Return on Equity:19%, within reach of 20% target.
-
Dividend:Quarterly dividend raised $0.04 to $1.00 per common share; payout ratio 47% (within 40%50% target range); dividend yield 3.4%.
-
LICAT Ratio:142%, down 3 percentage points from Q2, primarily on interest rates.
-
Book Value Per Share:Up 5% to $42.79.
-
Financial Leverage Ratio:24.1%.
-
Total CSM:$14.1 billion.
-
Capital Returned:$780 million to shareholders via dividends and buybacks; $246 million of shares repurchased under NCIB.
-
Asset Management Underlying Net Income:Up 6% to USD297 million, driven by GreenOak (incl. Bell Partners) and higher fee-related margins; MFS broadly flat.
-
MFS Flows:Gross flows USD25.5 billion; net outflows USD26.9 billion, primarily US retail equity mutual funds; ETF net flows over USD650 million; fixed income net inflows USD300 million.
-
GreenOak Fundraising:USD3.5 billion in the quarter; gross deployment USD7.1 billion; positive net flows of $4 billion; gross flows up 8%.
-
Canada Underlying Net Income:Up 6% to $422 million; reported net income $418 million.
-
Canada Wealth AUM/AUMA:Up 11% to $284 billion; wealth sales up 21%.
-
US Underlying Net Income:Up 32% to USD141 million; reported net income USD77 million; medical stop-loss sales up 62%.
-
Asia Underlying Net Income:Up 8% (constant currency) to $227 million; individual insurance sales up 9% to $937 million.
-
Asia Market Sales Growth:Malaysia +60%, India +33%, Indonesia +26%, Hong Kong +6% (adviser force expanded to over 4,100).
-
Insurance Sales:Up 12% overall, driven by Asia growth and group benefit sales in Canada and US.
-
Assumption Review Impact:One-time $33 million reduction in reported earnings (mainly Asia policyholder behavior); $1.2 billion balance sheet reclassification between CSM and risk adjustment (Canada).
Release Date: November 05, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Sun Life Financial Inc ( NYSE:SLF ) delivered double-digit underlying EPS growth of 10% and a strong ROE of 19%, with underlying net income of $1.15 billion, up from $1.05 billion last year.
-
The company saw higher underlying earnings across all four business groups, driven by a diversified business mix and solid insurance growth, with Canada, Asia, US stop-loss, and GreenOak all contributing.
-
Sun Life Financial Inc ( NYSE:SLF ) increased its quarterly dividend by $0.04 to $1 per common share, reflecting confidence in its financial strength and commitment to returning capital to shareholders.
-
GreenOak delivered strong underlying earnings growth, with gross flows up 8% and positive net flows of $4 billion, and the company launched a strategic partnership with Wilton Re to grow a reinsurance vehicle to USD10 billion.
-
The company maintained an industry-leading LICAT ratio of 142% and a strong capital position, providing flexibility to invest in growth and return capital to shareholders.
Negative Points
-
Reported net income was $785 million, down from $1.1 billion a year ago, reflecting unfavorable market-related impacts and acquisition and integration costs.
-
MFS experienced elevated net outflows of USD26.9 billion, primarily in US retail equity mutual funds, due to investors' preference for passive strategies and underweighting to technology stocks, with conditions expected to persist.
-
US employee benefits faced elevated long-term disability incidents and severity, consistent with industry trends, which are expected to persist in the near term and may take several quarters to reprice.
-
US dental underlying net income is expected to remain muted due to Medicaid membership declines and industry trends, with further repositioning needed.
-
Asia new business CSM declined year-over-year, primarily due to a competitive environment in Hong Kong, and margins, while healthy, are lower.
Q & A Highlights
Q: Can you break down the drivers of the strong US medical stop-loss results and discuss their sustainability into 2027? A: David Healy, President of Sun Life U.S., explained that earnings were up 45% year-over-year after adjusting for the prior-year reserve change. The improvement was primarily driven by pricing actions taken for the 1/1 cycle, which positioned the company well for volume and persistency growth. He noted that claims are in line with expectations and the company is well-positioned for continued success, benefiting from a hard market and differentiated capabilities.
Q: What is driving the elevated long-term disability (LTD) claims in the US, and what actions are being taken? A: CEO Kevin Strain confirmed that elevated LTD incidents and severity are consistent with industry-wide trends, with mental health claims being a notable factor. He outlined a three-pronged approach: 1) Focus on claims and clinical management to help people return to work, 2) Implement pricing actions to reflect the increased risk, and 3) Maintain expense discipline. He noted that repricing will take time, typically two to three years for the full book of business to renew.
Q: How should we think about the outlook for MFS given the persistent industry headwinds and outflows? A: A company representative (Ted) stated that the outflows are driven by industry dynamics, specifically the shift to passive strategies and the high concentration of equity indices. He expects these trends to persist. However, he highlighted that MFS has a highly variable cost structure (about two-thirds of costs are variable) and has a long history of managing expenses prudently. While there may be some negative operating leverage in an asset-decline environment, the firm will continue to invest in growth areas like ETFs, fixed income, and SMAs to drive long-term value.
Q: Can you provide an update on the US dental and state government businesses and the potential for further intangible write-downs? A: CEO Kevin Strain noted it's too early to tell how the new US administration might impact the business but is watching for policy changes. David Healy added that the company is repositioning its book, with direct contracts with state plans now at 70% of government premium revenue, up from 55%. CFO Tim Deacon stated that goodwill impairment testing occurs in Q4, but the company feels good about the business's repositioning. He noted that exiting unprofitable contracts could expose some customer relationship intangibles, but there is nothing material to report at this time.
Q: What is the outlook for GreenOak's fee-related earnings (FRE) margin? A: A company representative (Bart) explained that the current high-20s margin is not the target. The goal is to reach a 35%+ FRE margin. He views 2026 as a transition year focused on integrating five separate businesses into one, which has already led to centralized distribution and consolidated corporate functions. He is confident that these integration efforts will unlock significant revenue and expense synergies, driving the margin expansion.
Q: How is Sun Life positioned to achieve its 20% ROE target given the current business mix? A: CFO Tim Deacon stated the company is making great progress towards its 20% medium-term objective, having ended the quarter at 19%. He noted that the world has evolved since the target was set in 2024. While the US business remains a growth driver, Canada and Asia have become larger contributors, and GreenOak is now contributing more than originally projected. He expressed strong conviction in the target, highlighting the power of the company's diversified business mix.
Q: Why is the Canadian group disability experience holding up better than the US and Canadian peers? A: Jessica Tan, President of Sun Life Canada, attributed the performance to disciplined pricing and margin actions over time. She noted that the Canadian market is structurally different, with a focus on long-duration policies (five years and beyond). CEO Kevin Strain added that in Canada, Sun Life typically provides the entire benefits program for a client, allowing for deeper relationships, whereas in the US, it may only be a piece of the program. He also noted the difference in the healthcare system, where losing a job in Canada doesn't mean losing healthcare.
Q: What is the outlook for the US stop-loss business heading into the January 1, 2027 renewals? A: David Healy, President of Sun Life U.S., expressed confidence in the company's position, citing a large and encouraging pipeline. He believes the company is well-positioned from a pricing standpoint and with its differentiated capabilities. He expects the stop-loss market to remain hard through the 1/1 cycle and sees the company continuing to build on its recent growth.
Q: Can you discuss the sustainability of the recent decline in expenses? A: CFO Tim Deacon confirmed that the 5% year-over-year decline in expenses is primarily due to a continued focus on expense discipline across all businesses. He noted that the benefits from a restructuring program started in 2024 are now coming through. While there will always be some quarter-to-quarter variability, he views the average expense level seen through 2026 as a good base and expects the company to remain disciplined on costs.
Q: What is driving the growth in Asia, and how do you view the outlook for new business CSM? A: Manjit Singh, President of Sun Life Asia, highlighted that year-to-date earnings are up 14%, and he remains comfortable with generating double-digit growth going forward, attributing the Q3 slowdown to a strong prior-year comparison. He noted that new business CSM declined due to a competitive environment in Hong Kong, but margins remain healthy and are expected to be stable. Sales growth was strong in Malaysia, India, and Indonesia, supported by bancassurance.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
